Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Seroma 3 Pancreatic Neoplasms 2 Rectal Diseases 1 Prostatic Neoplasms 1 Patient Satisfaction 1 Pancreatitis 1 Pain, Postoperative 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms by Site 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Colorectal Neoplasms 1

Interventions

Bupivacaine 31 Ropivacaine 19 Dexmedetomidine 19 Saline Solution 18 Morphine 12 Ketamine 12 Sodium Chloride 10 Pregabalin 9 Lidocaine 9 Acetaminophen 9 Control Groups 7 Injections, Epidural 5 Gabapentin 4 Epinephrine 4 Dexamethasone 4 Anesthetics, Local 4 Anesthesia, General 4 Analgesia, Patient-Controlled 4 parecoxib 3 oxycodone-acetaminophen 3 Tea 3 Midazolam 3 Ketorolac 3 Fentanyl 3 Esketamine 3 Dental Occlusion 3 Vitamins 2 Tramadol 2 Surgical Procedures, Operative 2 Sufentanil 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain, Postoperative × Drainage × Clear all

NCT04974125 2026-03-18

DRAIN-EXSU

Centre Oscar Lambret

Phase NA Completed

Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡